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Summary Histological examination of adequate biopsy specimens is fundamental to the management of
patients with non-Hodgkin's lymphoma (NHL). A practical alternative to open biopsy, provided enough tissue
can be obtained, has obvious advantages, especially if the lesion in question is deep seated, and might call for
laparotomy or thoracotomy. Core biopsy with computed tomography (CT) or ultrasound (US) guidance may
be such an alternative, particularly when a spring-loaded firing device is used. Thirty-four biopsies were
performed in 26 patients with known or suspected NHL. A primary histological diagnosis was made in 7/7 (six
NHL, one seminoma). Relapse was confirmed in 15/15 patients overall. In patients with follicular NHL, 8/15
biopsies showed progression to high grade histology. Biopsies were also performed to assess the nature of
residual abnormalities after treatment and to obtain fresh tissue for immunocytochemistry. Tissue was
obtained in all cases and a further procedure (two laparotomies, one second needle biopsy) was required on
only three occasions. The procedure was well tolerated and there were no complications. This technique is
therefore a valuable alternative to more invasive surgical procedures and may be of major benefit in the
management of NHL.
Tissue biopsy allowing histological classification is essential
for defining the optimal management of patients with non-
Hodgkin's lymphoma. It is necessary for establishing a diag-
nosis, contributing information about natural history,
responsiveness to therapy and prognosis. Repeat biopsy may
be required to confirm relapse or progression of disease,
especially when transformation of follicular lymphoma to
high grade histology is suspected (Cullen et al., 1979; Hub-
bard et al., 1982; Gallagher et al., 1986), and to define the
nature of radiological abnormalities remaining after therapy.
Immunocytochemical analysis is an important adjunct to
morphological diagnosis but requires extra tissue. Further-
more, certain differentiation antigens can only be detected
using fresh tissue (Cossman et al., 1984; Pallesen, 1988).
The mainstay of tissue diagnosis in lymphoma is excision
biopsy of peripheral lymph nodes. In the absence of palpable
disease, resort has been made to more invasive methods such
as laparotomy and mediastinotomy but these require general
anaesthesia, carry significant morbidity, and are expensive
and time consuming. In patients with intra-abdominal and
mediastinal disease, guided needle biopsy may offer an alter-
native. However, in the past, this technique has been limited
to providing cytological material only and therefore has been
of limited application in lymphoma where morphological
accuracy requires more substantial tissue, particularly to
determine nodularity (Zornoza et al., 1981; Buscarini et al.,
1985; Pontifex & Klimo, 1984; Webb et al., 1989). The use of
a spring loaded device to fire a cutting needle has stimulated
radiologists to sample otherwise inaccessible tissue and
obtain specimens suitable for histologic examination. The use
of this device, the Biopty Gun (Radiplast Biopty, Henleys
Medical Supplies Ltd, London) was evaluated, at the time of
diagnosis or at relapse, in a series of patients with known or
suspected non-Hodgkin's lymphoma.
Patients and methods
Patients
Twenty-six patients in whom radiological evaluation con-
firmed that appropriate tissue was amenable to biopsy form
the basis of this report. Thirteen men and 13 women with a
median age of 50 years (range 30-86) had 34 biopsies. The
indications for biopsy are shown in Table I.
Seven patients had more than one biopsy. A 66 year old
woman with a 12 year history of follicular lymphoma had
tissue sampled at three separate relapses. Confirmation of a
further relapse was made by second biopsy in three other
patients. Fresh tissue for immunophenotyping was needed in
two patients, one of whom had had an earlier diagnostic
biopsy, the other later requiring clarification of the nature of
a residual mass after therapy. An initial biopsy in another
patient with suspected relapse of high grade lymphoma
garnered fibrous tissue only and a second biopsy was there-
fore performed.
The platelet count and clotting screen were normal in all
patients except one man with a platelet count of 33 x IO 1-
who was successfully biopsied under platelet cover.
Site and extent ofdisease biopsied
A mass had been previously identified in all patients either by
computed tomography or ultrasound scanning. The site of
disease was intra-abdominal in 27 cases, pelvic in four and
intrathoracic in three cases. The intra-abdominal sites
included the mesentery in eight and the retroperitoneum in
ten. One was intrahepatic. The maximum dimensions ranged
from 3-19 cm (approximate volume: 94-1,853 ml).
Biopsy technique
Twenty-eight biopsies were performed under CT (25 abdom-
inal, three thoracic) and six under US guidance. The choice
of imaging guidance was based predominantly on likely ease
of access for the biopsy. Limited confirmatory scanning was
performed in an appropriate position. The skin was then
cleaned and sterile towels applied. Local anaesthesia was
obtained using 1% lignocaine injected down to the level of
Table I Indications for biopsy
Indicationsfor biopsy Number ofpatients
Diagnosis: 7
Suspected relapse:
Follicular: 11
High Grade: 4
Evaluation of residual radiological abnormality 3
Fresh tissue for immunocytochemistry I
Total 26
Correspondence: J. Whelan, ICRF Department of Medical
Oncology, St Bartholomew's Hospital, West Smithfield, London
EClA 7BE, UK.
Received 16 August 1990; and in revised form 31 October 1990.
Br. J. Cancer (I991), 63, 460 462 '." Macmillan Press Ltd., 1991CT- AND US-GUIDED BIOPSY IN NON-HODGKIN'S LYMPHOMA 461
the lesion. The Biopty Gun was loaded with a 14G needle to
ensure an adequate sample in all except one patient in whom
an 18G needle was used.
When ultrasound was used, a 2 mm skin incision was made
at the chosen site. The transducer was sterilised and under
real time guidance the assembled Biopty Gun advanced to
the edge of the lesion. The single handed operation of this
instrument allows the operator a hand free to perform the
scanning. After releasing the safety catch and warning the
patient of the noise of the 'gun's' discharge, the sample was
taken. At least two passes were made to provide both fresh
and formalin fixed tissue specimens. When CT guidance was
used, the patient was prepared as described above, a 20G
spinal needle was advanced into the lesion and a scan
obtained to check the position. The exact site, depth and
angulation were noted and reproduced using the Biopty Gun,
allowing for a 2.3 cm 'throw'. The samples were then obtain-
ed as above.
Tissue samples were treated routinely. Immunocytochemis-
try was performed using a well-characterised panel of mono-
clonal antibodies directed against B and T antigens, on either
fresh tissue or paraffin sections. Drying artefact in the former
was avoided by placing samples directly into phosphate
buffered saline.
Informed consent was obtained from all patients. Premedi-
cation was not routinely given but sedation was occasionally
employed in anxious individuals. All patients were observed
overnight in hospital after the procedure. Simple analgesia
was given as appropriate.
Results
Tissue samples were obtained at all 34 attempts. The proce-
dure was well tolerated on every occasion and there were no
complications. An initial diagnosis was made in the seven
patients with suspected lymphoma, six of whom proved to
have NHL and one seminoma. Three patients had diffuse,
high grade lymphoma and three low grade lymphoma (Kiel
Classification, Gerard-Marchant et al., 1974). A follicular
pattern was evident in one of the latter biopsies, suspected
and subsequently confirmed at laparotomy in a second
patient but the third biopsy could not be characterised
beyond 'low grade'.
Fifteen biopsies were performed in 11 patients with pre-
viously diagnosed centroblastic/centrocytic, follicular lymph-
oma. Progression to high grade histology was found in eight
patients, with a persistent follicular pattern apparent in the
other three. Two patients who were then treated for high
grade lymphoma had further biopsies at subsequent relapse,
once more confirming centroblastic lymphoma.
Suspected relapse of high grade lymphoma was verified at
re-biopsy in 4/4 patients. However, two procedures were
required in a man with previously treated stage IV high grade
lymphoma with liver involvement. The first biopsy was of a
retroperitoneal mass which on radiological review showed no
features of progression since the end of previous therapy.
Only fibrous tissue was obtained but the relapse was subse-
quently confirmed at a second guided biopsy, of the liver. In
another patient with previously treated immunoblastic lym-
phoma, core biopsy at relapse included features consistent
with transformation from lymphoplasmacytoid lymphoma
although this was not seen in the original diagnostic speci-
men, a peripheral lymph node.
Three patients had biopsies of abdominal masses persisting after chemotherapy for high grade lymphoma. In one, a
biopsy showed fibrous tissue only and complete remission
was confirmed at laparotomy. Two other patients were
shown to have residual follicular, centroblastic/centrocytic lymphoma with no features ofhigh grade histology and were
then treated accordingly.
Fibrous tissue alone was found in another patient, in
whom a biopsy was performed to obtain fresh tissue for
immunocytochemistry. This represents a 'false negative' result but no further procedure was deemed appropriate.
Discussion
Alternatives to open biopsy in the diagnosis and management
of mediastinal and intra-abdominal masses have been explor-
ed for more than a decade as experience of imaging tech-
niques such as ultrasound and computed tomography has
grown (Haaga, 1979; Staab et al., 1979; Husband & Golding,
1983; Ferrucci et al., 1980). Several authors have reported the
use of guided biopsy in patients with Hodgkin's disease and
non-Hodgkin's lymphoma, in particular using fine needle
aspiration to provide material for cytological analysis (Zor-
noza et al., 1981; Buscarini et al., 1985; Pontifex & Klimo,
1984; Webb et al., 1989). The latter technique has the poten-
tial advantage of speed in making a diagnosis in the gravely
ill patient but rarely provides adequate morphological in-
formation to fully characterise non-Hodgkin's lymphomas;
importantly, nodularity is difficult to determine. Immuno-
cytochemistry is also less satisfactory.
Haaga first described the use of a cutting needle for retro-
peritoneal biopsies, but in his series of 29 cases only four
were lymphomas, two of which were successfully diagnosed
(Haaga, 1979). Others have compared the use of fine needle
with cutting needle biopsies and shown an advantage for the
latter in the diagnosis and classification of lymphomas in
addition to other benign and malignant conditions (Haaga et
al., 1983; Erwin et al., 1986; Goralnik et al., 1988; Jennings
et al., 1989; Knelson et al., 1989). Lindgren's development of
a hand-held device for automatically firing a Tru-cut needle
(Travenol Laboratories) represented a major advance, allow-
ing precise control with consequent better specimen size and
preservation (Lindgren, 1982). In particular, the speed of
sampling with this device avoids the shearing artefact which
limited interpretation of needle biopsies obtained by conven-
tional methods. Wotherspoon et al. (1989) has described
using this device, the Biopty Gun, in 24 patients thought to
be unsuitable for open surgery, including six known or
thought to be HIV positive. A diagnosis of non-Hodgkin's
lymphoma with adequate morphological and immunocyto-
chemical details was made in 14 cases.
The experience reported above, however, suggests that core
biopsy with the Biopty Gun has applications beyond diag-
nosis in those unfit for laparotomy or mediastinotomy. Cor-
rect clinical information was provided in 30/31 diagnostic
procedures. Whilst sampling error might potentially have
been a problem in view of the relatively small size of the
biopsies, in fact this was not the case. Further characterisa-
tion of a lymphoma was deemed necessary on only one
occasion when a laparotomy was performed. One other
patient had a laparatomy which confirmed the single 'true
negative' result in this series. In contrast even to the most
recent experience with aspiration cytology (Tani et al., 1988;
Liliemark et al., 1989) assessment of follicles was possible
with this technique. Very large follicular structures might
potentially be missed, but this theoretical drawback was not
encountered. Primary diagnosis of rare lymphomas may also
be compromised by small samples, and as with biopsies
negative for lymphoma, open biopsy may be needed.
This series relates primarily to patients requiring biopsy at
the time of recurrence rather than patients at first presenta-
tion reflecting the referral pattern at this centre, in that
patients are usually seen when the primary diagnosis has
been made and a stringent policy of re-biopsy at relapse is
followed, particularly in patients with follicular lymphoma.
Detection of histological transformation at relapse is inval-
uable, allowing early adjustment of treatment with the poten-
tial for improving the currently poor prognosis in this group
of patients (Gallagher et al., 1986). The benefits of this
technique in patients with residual masses after treatment
were also demonstrated, the results substantially influencing
subsequent management in all three cases. Ample tissue was
available for immunocytochemistry; on only one occasion
was the sample too small to allow planned immunophenotyp-
ing studies. Gene rearrangement studies could have been
performed on the amount of tissue obtained had they been
required. The choice of CT or ultrasound guidance is based462 J.S. WHELAN et al.
on the preference of the radiologist and availability of equip-
ment, at this centre, CT being considered preferable for
visualising the retro-peritoneum.
In summary, core needle biopsy using the Biopty Gun has
major value in the clinical management of non-Hodgkin's
lymphoma, providing a safe, quick and reliable alternative to
surgical tissue sampling without compromising lymphoma
characterisation. However, it requires particular expertise
from the radiologist and pathologist to both obtain and
interpret the small specimens. Furthermore, negative results
may require further clarification. More experience is needed
to define the place of core needle biopsy in mediastinal and
thoracic inlet disease when the potential risk of haemorrhage
and contrast-induced bronchospasm may outweigh the
advantages. In the absence of peripheral lymphadenopathy, it
is now the procedure of choice for histological sampling of
abdominal disease in non-Hodgkin's lymphoma.
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